nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetophenazine—DRD1—Parkinson's disease	0.518	0.586	CbGaD
Acetophenazine—DRD2—Parkinson's disease	0.365	0.413	CbGaD
Acetophenazine—DRD1—telencephalic ventricle—Parkinson's disease	0.0084	0.203	CbGeAlD
Acetophenazine—DRD1—nerve—Parkinson's disease	0.00529	0.128	CbGeAlD
Acetophenazine—DRD2—telencephalic ventricle—Parkinson's disease	0.00496	0.12	CbGeAlD
Acetophenazine—DRD1—Dopamine receptors—DRD2—Parkinson's disease	0.00392	0.0594	CbGpPWpGaD
Acetophenazine—DRD2—Dopamine receptors—DRD1—Parkinson's disease	0.00338	0.0512	CbGpPWpGaD
Acetophenazine—DRD2—Dopamine receptors—DRD3—Parkinson's disease	0.00328	0.0496	CbGpPWpGaD
Acetophenazine—DRD2—nerve—Parkinson's disease	0.00313	0.0756	CbGeAlD
Acetophenazine—DRD2—Nicotine Activity on Dopaminergic Neurons—PPP1R1B—Parkinson's disease	0.00251	0.0381	CbGpPWpGaD
Acetophenazine—DRD2—hindbrain—Parkinson's disease	0.00234	0.0566	CbGeAlD
Acetophenazine—DRD1—brainstem—Parkinson's disease	0.00227	0.055	CbGeAlD
Acetophenazine—DRD1—forebrain—Parkinson's disease	0.00219	0.053	CbGeAlD
Acetophenazine—DRD2—Nicotine Activity on Dopaminergic Neurons—DDC—Parkinson's disease	0.00172	0.026	CbGpPWpGaD
Acetophenazine—DRD2—Nicotine Activity on Dopaminergic Neurons—SLC18A2—Parkinson's disease	0.00146	0.0221	CbGpPWpGaD
Acetophenazine—DRD1—midbrain—Parkinson's disease	0.00145	0.035	CbGeAlD
Acetophenazine—DRD1—Hypothetical Network for Drug Addiction—GRM5—Parkinson's disease	0.00142	0.0216	CbGpPWpGaD
Acetophenazine—DRD2—brainstem—Parkinson's disease	0.00134	0.0325	CbGeAlD
Acetophenazine—DRD2—forebrain—Parkinson's disease	0.0013	0.0313	CbGeAlD
Acetophenazine—DRD1—head—Parkinson's disease	0.00126	0.0304	CbGeAlD
Acetophenazine—DRD1—nervous system—Parkinson's disease	0.00119	0.0288	CbGeAlD
Acetophenazine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA4—Parkinson's disease	0.00115	0.0175	CbGpPWpGaD
Acetophenazine—DRD1—central nervous system—Parkinson's disease	0.00115	0.0277	CbGeAlD
Acetophenazine—DRD2—Hypothetical Network for Drug Addiction—GRM5—Parkinson's disease	0.00108	0.0163	CbGpPWpGaD
Acetophenazine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD3—Parkinson's disease	0.00104	0.0157	CbGpPWpGaD
Acetophenazine—DRD1—Monoamine GPCRs—HTR1A—Parkinson's disease	0.00103	0.0155	CbGpPWpGaD
Acetophenazine—DRD1—Monoamine GPCRs—DRD3—Parkinson's disease	0.000959	0.0145	CbGpPWpGaD
Acetophenazine—DRD2—Nicotine Activity on Dopaminergic Neurons—TH—Parkinson's disease	0.000957	0.0145	CbGpPWpGaD
Acetophenazine—DRD1—Hypothetical Network for Drug Addiction—GRIN2B—Parkinson's disease	0.000918	0.0139	CbGpPWpGaD
Acetophenazine—DRD1—brain—Parkinson's disease	0.00091	0.022	CbGeAlD
Acetophenazine—DRD1—Hypothetical Network for Drug Addiction—DRD2—Parkinson's disease	0.000889	0.0135	CbGpPWpGaD
Acetophenazine—DRD1—Monoamine GPCRs—HTR7—Parkinson's disease	0.000867	0.0131	CbGpPWpGaD
Acetophenazine—DRD1—Monoamine GPCRs—DRD2—Parkinson's disease	0.000867	0.0131	CbGpPWpGaD
Acetophenazine—DRD1—Amine ligand-binding receptors—HTR1A—Parkinson's disease	0.000862	0.013	CbGpPWpGaD
Acetophenazine—DRD2—midbrain—Parkinson's disease	0.000856	0.0207	CbGeAlD
Acetophenazine—Flupentixol—DDC—Parkinson's disease	0.000828	0.0886	CrCbGaD
Acetophenazine—DRD1—Amine ligand-binding receptors—DRD3—Parkinson's disease	0.000806	0.0122	CbGpPWpGaD
Acetophenazine—DRD2—Monoamine GPCRs—HTR1A—Parkinson's disease	0.000774	0.0117	CbGpPWpGaD
Acetophenazine—DRD2—Hypothetical Network for Drug Addiction—DRD1—Parkinson's disease	0.000766	0.0116	CbGpPWpGaD
Acetophenazine—DRD2—Monoamine GPCRs—DRD1—Parkinson's disease	0.000748	0.0113	CbGpPWpGaD
Acetophenazine—DRD2—head—Parkinson's disease	0.000742	0.0179	CbGeAlD
Acetophenazine—DRD1—Amine ligand-binding receptors—HTR7—Parkinson's disease	0.000729	0.011	CbGpPWpGaD
Acetophenazine—DRD1—Amine ligand-binding receptors—DRD2—Parkinson's disease	0.000729	0.011	CbGpPWpGaD
Acetophenazine—DRD2—Monoamine GPCRs—DRD3—Parkinson's disease	0.000724	0.011	CbGpPWpGaD
Acetophenazine—DRD2—nervous system—Parkinson's disease	0.000703	0.017	CbGeAlD
Acetophenazine—DRD2—Hypothetical Network for Drug Addiction—GRIN2B—Parkinson's disease	0.000693	0.0105	CbGpPWpGaD
Acetophenazine—DRD2—central nervous system—Parkinson's disease	0.000677	0.0164	CbGeAlD
Acetophenazine—DRD2—cerebellum—Parkinson's disease	0.000662	0.016	CbGeAlD
Acetophenazine—DRD2—Monoamine GPCRs—HTR7—Parkinson's disease	0.000655	0.00991	CbGpPWpGaD
Acetophenazine—DRD2—Amine ligand-binding receptors—HTR1A—Parkinson's disease	0.000651	0.00985	CbGpPWpGaD
Acetophenazine—DRD2—Amine ligand-binding receptors—DRD1—Parkinson's disease	0.000628	0.00951	CbGpPWpGaD
Acetophenazine—DRD2—Amine ligand-binding receptors—DRD3—Parkinson's disease	0.000609	0.00921	CbGpPWpGaD
Acetophenazine—DRD1—Monoamine GPCRs—HTR2A—Parkinson's disease	0.000607	0.00919	CbGpPWpGaD
Acetophenazine—DRD2—Amine ligand-binding receptors—HTR7—Parkinson's disease	0.00055	0.00833	CbGpPWpGaD
Acetophenazine—DRD2—brain—Parkinson's disease	0.000538	0.013	CbGeAlD
Acetophenazine—DRD1—Amine ligand-binding receptors—HTR2A—Parkinson's disease	0.000511	0.00773	CbGpPWpGaD
Acetophenazine—DRD1—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.000489	0.00741	CbGpPWpGaD
Acetophenazine—DRD2—Monoamine GPCRs—HTR2A—Parkinson's disease	0.000459	0.00694	CbGpPWpGaD
Acetophenazine—DRD1—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.000419	0.00635	CbGpPWpGaD
Acetophenazine—DRD1—G alpha (s) signalling events—ADORA2A—Parkinson's disease	0.00041	0.0062	CbGpPWpGaD
Acetophenazine—DRD2—Amine ligand-binding receptors—HTR2A—Parkinson's disease	0.000386	0.00584	CbGpPWpGaD
Acetophenazine—DRD1—Circadian rythm related genes—DDC—Parkinson's disease	0.000373	0.00565	CbGpPWpGaD
Acetophenazine—DRD2—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.00037	0.00559	CbGpPWpGaD
Acetophenazine—DRD1—GPCR ligand binding—GPR37—Parkinson's disease	0.000319	0.00483	CbGpPWpGaD
Acetophenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.000317	0.00479	CbGpPWpGaD
Acetophenazine—DRD1—G alpha (s) signalling events—HTR7—Parkinson's disease	0.000301	0.00455	CbGpPWpGaD
Acetophenazine—DRD2—Circadian rythm related genes—DDC—Parkinson's disease	0.000282	0.00426	CbGpPWpGaD
Acetophenazine—DRD1—Circadian rythm related genes—ADORA2A—Parkinson's disease	0.000278	0.00421	CbGpPWpGaD
Acetophenazine—DRD2—G alpha (i) signalling events—GRM4—Parkinson's disease	0.000271	0.0041	CbGpPWpGaD
Acetophenazine—DRD1—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00027	0.00409	CbGpPWpGaD
Acetophenazine—DRD2—G alpha (i) signalling events—PENK—Parkinson's disease	0.000257	0.00388	CbGpPWpGaD
Acetophenazine—Flupentixol—DRD1—Parkinson's disease	0.000254	0.0271	CrCbGaD
Acetophenazine—DRD1—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.000247	0.00374	CbGpPWpGaD
Acetophenazine—DRD2—GPCR ligand binding—GPR37—Parkinson's disease	0.000241	0.00365	CbGpPWpGaD
Acetophenazine—DRD2—G alpha (i) signalling events—PDYN—Parkinson's disease	0.000235	0.00355	CbGpPWpGaD
Acetophenazine—DRD1—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.000228	0.00345	CbGpPWpGaD
Acetophenazine—DRD1—Circadian rythm related genes—DRD3—Parkinson's disease	0.000226	0.00342	CbGpPWpGaD
Acetophenazine—DRD1—GPCR ligand binding—GRM4—Parkinson's disease	0.000217	0.00329	CbGpPWpGaD
Acetophenazine—DRD2—Circadian rythm related genes—ADORA2A—Parkinson's disease	0.00021	0.00318	CbGpPWpGaD
Acetophenazine—DRD1—Circadian rythm related genes—TH—Parkinson's disease	0.000208	0.00315	CbGpPWpGaD
Acetophenazine—DRD1—GPCR ligand binding—PENK—Parkinson's disease	0.000206	0.00311	CbGpPWpGaD
Acetophenazine—DRD1—Circadian rythm related genes—DRD2—Parkinson's disease	0.000204	0.00309	CbGpPWpGaD
Acetophenazine—DRD1—Circadian rythm related genes—HTR7—Parkinson's disease	0.000204	0.00309	CbGpPWpGaD
Acetophenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.000204	0.00309	CbGpPWpGaD
Acetophenazine—Propericiazine—DRD1—Parkinson's disease	0.000199	0.0213	CrCbGaD
Acetophenazine—DRD1—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.000198	0.00299	CbGpPWpGaD
Acetophenazine—DRD1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.000195	0.00296	CbGpPWpGaD
Acetophenazine—DRD1—GPCR ligand binding—PDYN—Parkinson's disease	0.000188	0.00285	CbGpPWpGaD
Acetophenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.000187	0.00282	CbGpPWpGaD
Acetophenazine—DRD1—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.000185	0.0028	CbGpPWpGaD
Acetophenazine—DRD1—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00018	0.00273	CbGpPWpGaD
Acetophenazine—Flupentixol—DRD2—Parkinson's disease	0.000179	0.0191	CrCbGaD
Acetophenazine—DRD2—Circadian rythm related genes—DRD1—Parkinson's disease	0.000176	0.00267	CbGpPWpGaD
Acetophenazine—DRD1—GPCR ligand binding—GRM5—Parkinson's disease	0.000175	0.00265	CbGpPWpGaD
Acetophenazine—DRD2—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.000172	0.00261	CbGpPWpGaD
Acetophenazine—DRD2—Circadian rythm related genes—DRD3—Parkinson's disease	0.000171	0.00258	CbGpPWpGaD
Acetophenazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00017	0.00257	CbGpPWpGaD
Acetophenazine—DRD1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.000167	0.00253	CbGpPWpGaD
Acetophenazine—DRD1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.000167	0.00253	CbGpPWpGaD
Acetophenazine—DRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000167	0.00253	CbGpPWpGaD
Acetophenazine—DRD2—GPCR ligand binding—GRM4—Parkinson's disease	0.000164	0.00248	CbGpPWpGaD
Acetophenazine—DRD1—Signaling by GPCR—DGKQ—Parkinson's disease	0.000164	0.00248	CbGpPWpGaD
Acetophenazine—DRD1—Signaling by GPCR—GPR37—Parkinson's disease	0.000164	0.00248	CbGpPWpGaD
Acetophenazine—DRD2—G alpha (i) signalling events—HTR1A—Parkinson's disease	0.000161	0.00244	CbGpPWpGaD
Acetophenazine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000159	0.0024	CbGpPWpGaD
Acetophenazine—DRD2—Circadian rythm related genes—TH—Parkinson's disease	0.000157	0.00238	CbGpPWpGaD
Acetophenazine—DRD2—GPCR ligand binding—PENK—Parkinson's disease	0.000155	0.00235	CbGpPWpGaD
Acetophenazine—DRD2—Circadian rythm related genes—HTR7—Parkinson's disease	0.000154	0.00234	CbGpPWpGaD
Acetophenazine—DRD2—G alpha (i) signalling events—DRD3—Parkinson's disease	0.000151	0.00228	CbGpPWpGaD
Acetophenazine—DRD1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00015	0.00227	CbGpPWpGaD
Acetophenazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.000149	0.00226	CbGpPWpGaD
Acetophenazine—DRD1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000149	0.00225	CbGpPWpGaD
Acetophenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.000148	0.00223	CbGpPWpGaD
Acetophenazine—DRD2—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.000144	0.00218	CbGpPWpGaD
Acetophenazine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000143	0.00217	CbGpPWpGaD
Acetophenazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000143	0.00217	CbGpPWpGaD
Acetophenazine—Zuclopenthixol—DRD1—Parkinson's disease	0.000143	0.0153	CrCbGaD
Acetophenazine—DRD2—GPCR ligand binding—PDYN—Parkinson's disease	0.000142	0.00215	CbGpPWpGaD
Acetophenazine—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00014	0.00212	CbGpPWpGaD
Acetophenazine—Flupentixol—HTR2A—Parkinson's disease	0.000138	0.0148	CrCbGaD
Acetophenazine—Triflupromazine—DRD1—Parkinson's disease	0.000138	0.0148	CrCbGaD
Acetophenazine—Ranolazine—CYP2D6—Parkinson's disease	0.000137	0.0147	CrCbGaD
Acetophenazine—DRD1—GPCR downstream signaling—GRK5—Parkinson's disease	0.000137	0.00207	CbGpPWpGaD
Acetophenazine—DRD2—GPCR downstream signaling—DGKQ—Parkinson's disease	0.000136	0.00206	CbGpPWpGaD
Acetophenazine—Nefazodone—SLC6A3—Parkinson's disease	0.000134	0.0144	CrCbGaD
Acetophenazine—DRD2—GPCR ligand binding—GRM5—Parkinson's disease	0.000132	0.002	CbGpPWpGaD
Acetophenazine—Hydroxyzine—CYP2D6—Parkinson's disease	0.000132	0.0141	CrCbGaD
Acetophenazine—DRD1—GPCR ligand binding—HTR1A—Parkinson's disease	0.000129	0.00195	CbGpPWpGaD
Acetophenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.000128	0.00194	CbGpPWpGaD
Acetophenazine—Acepromazine—DRD1—Parkinson's disease	0.000128	0.0137	CrCbGaD
Acetophenazine—DRD1—GPCR ligand binding—TAC1—Parkinson's disease	0.000127	0.00192	CbGpPWpGaD
Acetophenazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.000126	0.00191	CbGpPWpGaD
Acetophenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000126	0.00191	CbGpPWpGaD
Acetophenazine—Thioproperazine—DRD1—Parkinson's disease	0.000125	0.0134	CrCbGaD
Acetophenazine—DRD1—Signaling by GPCR—GRK5—Parkinson's disease	0.000124	0.00188	CbGpPWpGaD
Acetophenazine—DRD2—Signaling by GPCR—DGKQ—Parkinson's disease	0.000124	0.00187	CbGpPWpGaD
Acetophenazine—DRD2—Signaling by GPCR—GPR37—Parkinson's disease	0.000124	0.00187	CbGpPWpGaD
Acetophenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000124	0.00187	CbGpPWpGaD
Acetophenazine—Mesoridazine—DRD3—Parkinson's disease	0.000124	0.0132	CrCbGaD
Acetophenazine—Thiothixene—DRD1—Parkinson's disease	0.000123	0.0132	CrCbGaD
Acetophenazine—Pipotiazine—DRD1—Parkinson's disease	0.000123	0.0132	CrCbGaD
Acetophenazine—DRD1—GPCR downstream signaling—GRM4—Parkinson's disease	0.000123	0.00186	CbGpPWpGaD
Acetophenazine—DRD1—GPCR ligand binding—DRD3—Parkinson's disease	0.000121	0.00183	CbGpPWpGaD
Acetophenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00012	0.00181	CbGpPWpGaD
Acetophenazine—Prochlorperazine—DRD3—Parkinson's disease	0.00012	0.0128	CrCbGaD
Acetophenazine—Nefazodone—HTR1A—Parkinson's disease	0.000118	0.0126	CrCbGaD
Acetophenazine—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000117	0.00177	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—VPS35—Parkinson's disease	0.000117	0.00177	CbGpPWpGaD
Acetophenazine—DRD1—GPCR downstream signaling—PENK—Parkinson's disease	0.000116	0.00176	CbGpPWpGaD
Acetophenazine—DRD1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000115	0.00174	CbGpPWpGaD
Acetophenazine—DRD2—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000113	0.00171	CbGpPWpGaD
Acetophenazine—DRD2—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000112	0.0017	CbGpPWpGaD
Acetophenazine—DRD1—Signaling by GPCR—GRM4—Parkinson's disease	0.000111	0.00169	CbGpPWpGaD
Acetophenazine—DRD1—GPCR ligand binding—DRD2—Parkinson's disease	0.000109	0.00165	CbGpPWpGaD
Acetophenazine—DRD1—GPCR ligand binding—HTR7—Parkinson's disease	0.000109	0.00165	CbGpPWpGaD
Acetophenazine—Trazodone—HTR1A—Parkinson's disease	0.000109	0.0117	CrCbGaD
Acetophenazine—Cyamemazine—HTR2A—Parkinson's disease	0.000108	0.0116	CrCbGaD
Acetophenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000108	0.00164	CbGpPWpGaD
Acetophenazine—Fluphenazine—DRD3—Parkinson's disease	0.000108	0.0116	CrCbGaD
Acetophenazine—DRD1—GPCR downstream signaling—PDYN—Parkinson's disease	0.000106	0.00161	CbGpPWpGaD
Acetophenazine—Fluphenazine—DRD1—Parkinson's disease	0.000106	0.0114	CrCbGaD
Acetophenazine—Acepromazine—HTR1A—Parkinson's disease	0.000106	0.0114	CrCbGaD
Acetophenazine—DRD1—Signaling by GPCR—PENK—Parkinson's disease	0.000106	0.0016	CbGpPWpGaD
Acetophenazine—Thioproperazine—HTR1A—Parkinson's disease	0.000104	0.0111	CrCbGaD
Acetophenazine—DRD2—GPCR downstream signaling—GRK5—Parkinson's disease	0.000103	0.00156	CbGpPWpGaD
Acetophenazine—Propiomazine—DRD1—Parkinson's disease	0.000102	0.0109	CrCbGaD
Acetophenazine—Pipotiazine—HTR1A—Parkinson's disease	0.000102	0.0109	CrCbGaD
Acetophenazine—Thiothixene—HTR1A—Parkinson's disease	0.000102	0.0109	CrCbGaD
Acetophenazine—Mesoridazine—HTR1A—Parkinson's disease	0.000101	0.0108	CrCbGaD
Acetophenazine—Zuclopenthixol—DRD2—Parkinson's disease	0.000101	0.0108	CrCbGaD
Acetophenazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.0001	0.00152	CbGpPWpGaD
Acetophenazine—Thioridazine—HTR7—Parkinson's disease	9.92e-05	0.0106	CrCbGaD
Acetophenazine—DRD1—GPCR downstream signaling—GRM5—Parkinson's disease	9.89e-05	0.0015	CbGpPWpGaD
Acetophenazine—DRD2—GPCR ligand binding—HTR1A—Parkinson's disease	9.75e-05	0.00148	CbGpPWpGaD
Acetophenazine—Triflupromazine—DRD2—Parkinson's disease	9.74e-05	0.0104	CrCbGaD
Acetophenazine—DRD1—Signaling Pathways—DGKQ—Parkinson's disease	9.68e-05	0.00147	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—GPR37—Parkinson's disease	9.68e-05	0.00147	CbGpPWpGaD
Acetophenazine—DRD1—Signaling by GPCR—PDYN—Parkinson's disease	9.66e-05	0.00146	CbGpPWpGaD
Acetophenazine—DRD2—GPCR ligand binding—TAC1—Parkinson's disease	9.6e-05	0.00145	CbGpPWpGaD
Acetophenazine—DRD2—GPCR ligand binding—DRD1—Parkinson's disease	9.41e-05	0.00142	CbGpPWpGaD
Acetophenazine—DRD2—Signaling by GPCR—GRK5—Parkinson's disease	9.38e-05	0.00142	CbGpPWpGaD
Acetophenazine—DRD2—GPCR downstream signaling—GRM4—Parkinson's disease	9.26e-05	0.0014	CbGpPWpGaD
Acetophenazine—Thioridazine—DRD1—Parkinson's disease	9.15e-05	0.00979	CrCbGaD
Acetophenazine—DRD2—GPCR ligand binding—DRD3—Parkinson's disease	9.12e-05	0.00138	CbGpPWpGaD
Acetophenazine—Perphenazine—HTR7—Parkinson's disease	9.1e-05	0.00974	CrCbGaD
Acetophenazine—Flupentixol—ABCB1—Parkinson's disease	9.03e-05	0.00966	CrCbGaD
Acetophenazine—Acepromazine—DRD2—Parkinson's disease	9.01e-05	0.00964	CrCbGaD
Acetophenazine—DRD1—Signaling by GPCR—GRM5—Parkinson's disease	8.98e-05	0.00136	CbGpPWpGaD
Acetophenazine—Quetiapine—HTR7—Parkinson's disease	8.93e-05	0.00955	CrCbGaD
Acetophenazine—Methotrimeprazine—DRD3—Parkinson's disease	8.9e-05	0.00953	CrCbGaD
Acetophenazine—DRD1—Signaling Pathways—PPP1R1B—Parkinson's disease	8.85e-05	0.00134	CbGpPWpGaD
Acetophenazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	8.85e-05	0.00134	CbGpPWpGaD
Acetophenazine—Fluphenazine—HTR1A—Parkinson's disease	8.82e-05	0.00944	CrCbGaD
Acetophenazine—DRD2—Signaling Pathways—VPS35—Parkinson's disease	8.82e-05	0.00134	CbGpPWpGaD
Acetophenazine—Thioproperazine—DRD2—Parkinson's disease	8.81e-05	0.00942	CrCbGaD
Acetophenazine—DRD2—GPCR downstream signaling—PENK—Parkinson's disease	8.78e-05	0.00133	CbGpPWpGaD
Acetophenazine—DRD1—GPCR ligand binding—EDN1—Parkinson's disease	8.74e-05	0.00132	CbGpPWpGaD
Acetophenazine—Methotrimeprazine—DRD1—Parkinson's disease	8.74e-05	0.00935	CrCbGaD
Acetophenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	8.67e-05	0.00131	CbGpPWpGaD
Acetophenazine—Thiothixene—DRD2—Parkinson's disease	8.67e-05	0.00927	CrCbGaD
Acetophenazine—Pipotiazine—DRD2—Parkinson's disease	8.67e-05	0.00927	CrCbGaD
Acetophenazine—Mequitazine—CYP2D6—Parkinson's disease	8.61e-05	0.00921	CrCbGaD
Acetophenazine—Mesoridazine—DRD2—Parkinson's disease	8.55e-05	0.00915	CrCbGaD
Acetophenazine—DRD2—Signaling by GPCR—GRM4—Parkinson's disease	8.41e-05	0.00127	CbGpPWpGaD
Acetophenazine—DRD1—GPCR downstream signaling—ADORA2A—Parkinson's disease	8.41e-05	0.00127	CbGpPWpGaD
Acetophenazine—Perphenazine—DRD1—Parkinson's disease	8.4e-05	0.00899	CrCbGaD
Acetophenazine—Quetiapine—DRD3—Parkinson's disease	8.39e-05	0.00898	CrCbGaD
Acetophenazine—Prochlorperazine—DRD2—Parkinson's disease	8.28e-05	0.00886	CrCbGaD
Acetophenazine—DRD2—GPCR ligand binding—HTR7—Parkinson's disease	8.24e-05	0.00125	CbGpPWpGaD
Acetophenazine—Quetiapine—DRD1—Parkinson's disease	8.24e-05	0.00881	CrCbGaD
Acetophenazine—DRD2—GPCR downstream signaling—PDYN—Parkinson's disease	8.03e-05	0.00122	CbGpPWpGaD
Acetophenazine—DRD2—Signaling by GPCR—PENK—Parkinson's disease	7.97e-05	0.00121	CbGpPWpGaD
Acetophenazine—DRD1—Circadian rythm related genes—MAPK8—Parkinson's disease	7.78e-05	0.00118	CbGpPWpGaD
Acetophenazine—Zuclopenthixol—HTR2A—Parkinson's disease	7.77e-05	0.00831	CrCbGaD
Acetophenazine—DRD1—Signaling Pathways—RIT2—Parkinson's disease	7.74e-05	0.00117	CbGpPWpGaD
Acetophenazine—Nefazodone—HTR2A—Parkinson's disease	7.72e-05	0.00826	CrCbGaD
Acetophenazine—DRD1—GPCR ligand binding—HTR2A—Parkinson's disease	7.65e-05	0.00116	CbGpPWpGaD
Acetophenazine—DRD1—Signaling by GPCR—ADORA2A—Parkinson's disease	7.63e-05	0.00116	CbGpPWpGaD
Acetophenazine—Thioridazine—HTR1A—Parkinson's disease	7.6e-05	0.00813	CrCbGaD
Acetophenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	7.58e-05	0.00115	CbGpPWpGaD
Acetophenazine—Promazine—DRD1—Parkinson's disease	7.57e-05	0.0081	CrCbGaD
Acetophenazine—Fluphenazine—DRD2—Parkinson's disease	7.49e-05	0.00801	CrCbGaD
Acetophenazine—DRD2—GPCR downstream signaling—GRM5—Parkinson's disease	7.47e-05	0.00113	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—GRK5—Parkinson's disease	7.34e-05	0.00111	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—GPR37—Parkinson's disease	7.31e-05	0.00111	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—DGKQ—Parkinson's disease	7.31e-05	0.00111	CbGpPWpGaD
Acetophenazine—DRD1—GPCR downstream signaling—HTR1A—Parkinson's disease	7.3e-05	0.0011	CbGpPWpGaD
Acetophenazine—DRD2—Signaling by GPCR—PDYN—Parkinson's disease	7.29e-05	0.0011	CbGpPWpGaD
Acetophenazine—Chlorpromazine—HTR7—Parkinson's disease	7.22e-05	0.00773	CrCbGaD
Acetophenazine—Fluphenazine—CYP2E1—Parkinson's disease	7.21e-05	0.00771	CrCbGaD
Acetophenazine—Propiomazine—DRD2—Parkinson's disease	7.2e-05	0.00771	CrCbGaD
Acetophenazine—DRD1—GPCR downstream signaling—TAC1—Parkinson's disease	7.18e-05	0.00109	CbGpPWpGaD
Acetophenazine—Trazodone—HTR2A—Parkinson's disease	7.15e-05	0.00765	CrCbGaD
Acetophenazine—Zuclopenthixol—CYP2D6—Parkinson's disease	7.1e-05	0.0076	CrCbGaD
Acetophenazine—Nefazodone—CYP2D6—Parkinson's disease	7.06e-05	0.00756	CrCbGaD
Acetophenazine—Trifluoperazine—HTR1A—Parkinson's disease	7.05e-05	0.00755	CrCbGaD
Acetophenazine—Perphenazine—HTR1A—Parkinson's disease	6.98e-05	0.00746	CrCbGaD
Acetophenazine—Acepromazine—HTR2A—Parkinson's disease	6.96e-05	0.00745	CrCbGaD
Acetophenazine—Quetiapine—HTR1A—Parkinson's disease	6.84e-05	0.00732	CrCbGaD
Acetophenazine—DRD1—GPCR downstream signaling—DRD3—Parkinson's disease	6.82e-05	0.00103	CbGpPWpGaD
Acetophenazine—Thioproperazine—HTR2A—Parkinson's disease	6.81e-05	0.00728	CrCbGaD
Acetophenazine—Chlorpromazine—DRD3—Parkinson's disease	6.79e-05	0.00726	CrCbGaD
Acetophenazine—DRD2—Signaling by GPCR—GRM5—Parkinson's disease	6.78e-05	0.00103	CbGpPWpGaD
Acetophenazine—Thiothixene—HTR2A—Parkinson's disease	6.7e-05	0.00716	CrCbGaD
Acetophenazine—Pipotiazine—HTR2A—Parkinson's disease	6.7e-05	0.00716	CrCbGaD
Acetophenazine—DRD2—Signaling Pathways—PPP1R1B—Parkinson's disease	6.68e-05	0.00101	CbGpPWpGaD
Acetophenazine—Chlorpromazine—DRD1—Parkinson's disease	6.66e-05	0.00713	CrCbGaD
Acetophenazine—DRD1—Signaling by GPCR—HTR1A—Parkinson's disease	6.62e-05	0.001	CbGpPWpGaD
Acetophenazine—Mesoridazine—HTR2A—Parkinson's disease	6.61e-05	0.00707	CrCbGaD
Acetophenazine—DRD2—GPCR ligand binding—EDN1—Parkinson's disease	6.6e-05	0.000999	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—GRM4—Parkinson's disease	6.58e-05	0.000996	CbGpPWpGaD
Acetophenazine—Trazodone—CYP2D6—Parkinson's disease	6.53e-05	0.00699	CrCbGaD
Acetophenazine—DRD1—Signaling by GPCR—TAC1—Parkinson's disease	6.52e-05	0.000988	CbGpPWpGaD
Acetophenazine—Thioridazine—DRD2—Parkinson's disease	6.45e-05	0.0069	CrCbGaD
Acetophenazine—DRD1—GPCR downstream signaling—ADRBK1—Parkinson's disease	6.37e-05	0.000964	CbGpPWpGaD
Acetophenazine—DRD2—GPCR downstream signaling—ADORA2A—Parkinson's disease	6.35e-05	0.000961	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—PENK—Parkinson's disease	6.24e-05	0.000944	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—MAG—Parkinson's disease	6.24e-05	0.000944	CbGpPWpGaD
Acetophenazine—Thioridazine—CYP2E1—Parkinson's disease	6.21e-05	0.00665	CrCbGaD
Acetophenazine—DRD1—Signaling by GPCR—DRD3—Parkinson's disease	6.2e-05	0.000938	CbGpPWpGaD
Acetophenazine—DRD1—GPCR downstream signaling—DRD2—Parkinson's disease	6.17e-05	0.000934	CbGpPWpGaD
Acetophenazine—DRD1—GPCR downstream signaling—HTR7—Parkinson's disease	6.17e-05	0.000934	CbGpPWpGaD
Acetophenazine—Methotrimeprazine—DRD2—Parkinson's disease	6.16e-05	0.00659	CrCbGaD
Acetophenazine—Thiothixene—CYP2D6—Parkinson's disease	6.12e-05	0.00655	CrCbGaD
Acetophenazine—Pipotiazine—CYP2D6—Parkinson's disease	6.12e-05	0.00655	CrCbGaD
Acetophenazine—Mesoridazine—CYP2D6—Parkinson's disease	6.04e-05	0.00647	CrCbGaD
Acetophenazine—Trifluoperazine—DRD2—Parkinson's disease	5.99e-05	0.00641	CrCbGaD
Acetophenazine—Methotrimeprazine—CYP2E1—Parkinson's disease	5.93e-05	0.00634	CrCbGaD
Acetophenazine—Perphenazine—DRD2—Parkinson's disease	5.92e-05	0.00634	CrCbGaD
Acetophenazine—DRD2—Circadian rythm related genes—MAPK8—Parkinson's disease	5.87e-05	0.000889	CbGpPWpGaD
Acetophenazine—Prochlorperazine—CYP2D6—Parkinson's disease	5.85e-05	0.00626	CrCbGaD
Acetophenazine—DRD2—Signaling Pathways—RIT2—Parkinson's disease	5.84e-05	0.000884	CbGpPWpGaD
Acetophenazine—Quetiapine—DRD2—Parkinson's disease	5.81e-05	0.00621	CrCbGaD
Acetophenazine—Fluphenazine—HTR2A—Parkinson's disease	5.79e-05	0.00619	CrCbGaD
Acetophenazine—DRD1—Signaling by GPCR—ADRBK1—Parkinson's disease	5.79e-05	0.000876	CbGpPWpGaD
Acetophenazine—DRD2—GPCR ligand binding—HTR2A—Parkinson's disease	5.77e-05	0.000874	CbGpPWpGaD
Acetophenazine—DRD2—Signaling by GPCR—ADORA2A—Parkinson's disease	5.76e-05	0.000873	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—PDYN—Parkinson's disease	5.71e-05	0.000864	CbGpPWpGaD
Acetophenazine—DRD1—Signaling by GPCR—DRD2—Parkinson's disease	5.6e-05	0.000848	CbGpPWpGaD
Acetophenazine—DRD1—Signaling by GPCR—HTR7—Parkinson's disease	5.6e-05	0.000848	CbGpPWpGaD
Acetophenazine—Propiomazine—HTR2A—Parkinson's disease	5.57e-05	0.00596	CrCbGaD
Acetophenazine—DRD2—Signaling Pathways—GRK5—Parkinson's disease	5.54e-05	0.000838	CbGpPWpGaD
Acetophenazine—Chlorpromazine—HTR1A—Parkinson's disease	5.53e-05	0.00592	CrCbGaD
Acetophenazine—DRD2—GPCR downstream signaling—HTR1A—Parkinson's disease	5.51e-05	0.000834	CbGpPWpGaD
Acetophenazine—DRD2—GPCR downstream signaling—TAC1—Parkinson's disease	5.42e-05	0.000821	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—GFAP—Parkinson's disease	5.36e-05	0.000812	CbGpPWpGaD
Acetophenazine—Promazine—DRD2—Parkinson's disease	5.34e-05	0.00571	CrCbGaD
Acetophenazine—DRD2—GPCR downstream signaling—DRD1—Parkinson's disease	5.32e-05	0.000805	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—GRM5—Parkinson's disease	5.3e-05	0.000803	CbGpPWpGaD
Acetophenazine—Fluphenazine—CYP2D6—Parkinson's disease	5.29e-05	0.00566	CrCbGaD
Acetophenazine—DRD2—GPCR downstream signaling—DRD3—Parkinson's disease	5.15e-05	0.00078	CbGpPWpGaD
Acetophenazine—Nefazodone—ABCB1—Parkinson's disease	5.04e-05	0.0054	CrCbGaD
Acetophenazine—DRD2—Signaling by GPCR—HTR1A—Parkinson's disease	5e-05	0.000757	CbGpPWpGaD
Acetophenazine—Thioridazine—HTR2A—Parkinson's disease	4.99e-05	0.00534	CrCbGaD
Acetophenazine—DRD2—Signaling Pathways—GRM4—Parkinson's disease	4.97e-05	0.000752	CbGpPWpGaD
Acetophenazine—DRD1—Circadian rythm related genes—IL6—Parkinson's disease	4.97e-05	0.000752	CbGpPWpGaD
Acetophenazine—DRD1—GPCR downstream signaling—EDN1—Parkinson's disease	4.94e-05	0.000748	CbGpPWpGaD
Acetophenazine—DRD2—Signaling by GPCR—TAC1—Parkinson's disease	4.93e-05	0.000746	CbGpPWpGaD
Acetophenazine—Triflupromazine—ABCB1—Parkinson's disease	4.91e-05	0.00526	CrCbGaD
Acetophenazine—DRD2—Signaling by GPCR—DRD1—Parkinson's disease	4.83e-05	0.000731	CbGpPWpGaD
Acetophenazine—DRD2—GPCR downstream signaling—ADRBK1—Parkinson's disease	4.81e-05	0.000728	CbGpPWpGaD
Acetophenazine—Methotrimeprazine—HTR2A—Parkinson's disease	4.76e-05	0.00509	CrCbGaD
Acetophenazine—DRD2—Signaling Pathways—PENK—Parkinson's disease	4.71e-05	0.000713	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—MAG—Parkinson's disease	4.71e-05	0.000713	CbGpPWpGaD
Acetophenazine—Chlorpromazine—DRD2—Parkinson's disease	4.7e-05	0.00503	CrCbGaD
Acetophenazine—DRD2—Signaling by GPCR—DRD3—Parkinson's disease	4.68e-05	0.000708	CbGpPWpGaD
Acetophenazine—Trazodone—ABCB1—Parkinson's disease	4.67e-05	0.00499	CrCbGaD
Acetophenazine—DRD2—GPCR downstream signaling—HTR7—Parkinson's disease	4.66e-05	0.000705	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—FGF20—Parkinson's disease	4.65e-05	0.000704	CbGpPWpGaD
Acetophenazine—Trifluoperazine—HTR2A—Parkinson's disease	4.63e-05	0.00495	CrCbGaD
Acetophenazine—Perphenazine—HTR2A—Parkinson's disease	4.58e-05	0.0049	CrCbGaD
Acetophenazine—Thioridazine—CYP2D6—Parkinson's disease	4.56e-05	0.00488	CrCbGaD
Acetophenazine—Chlorpromazine—CYP2E1—Parkinson's disease	4.52e-05	0.00484	CrCbGaD
Acetophenazine—DRD1—Signaling Pathways—ADORA2A—Parkinson's disease	4.51e-05	0.000683	CbGpPWpGaD
Acetophenazine—Quetiapine—HTR2A—Parkinson's disease	4.49e-05	0.0048	CrCbGaD
Acetophenazine—DRD1—Signaling by GPCR—EDN1—Parkinson's disease	4.49e-05	0.000679	CbGpPWpGaD
Acetophenazine—DRD2—Signaling by GPCR—ADRBK1—Parkinson's disease	4.37e-05	0.000661	CbGpPWpGaD
Acetophenazine—Methotrimeprazine—CYP2D6—Parkinson's disease	4.35e-05	0.00466	CrCbGaD
Acetophenazine—DRD1—GPCR downstream signaling—HTR2A—Parkinson's disease	4.32e-05	0.000654	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—PDYN—Parkinson's disease	4.31e-05	0.000652	CbGpPWpGaD
Acetophenazine—DRD2—Signaling by GPCR—HTR7—Parkinson's disease	4.23e-05	0.00064	CbGpPWpGaD
Acetophenazine—Perphenazine—CYP2D6—Parkinson's disease	4.18e-05	0.00448	CrCbGaD
Acetophenazine—DRD1—Signaling Pathways—INSR—Parkinson's disease	4.16e-05	0.00063	CbGpPWpGaD
Acetophenazine—Promazine—HTR2A—Parkinson's disease	4.13e-05	0.00441	CrCbGaD
Acetophenazine—Quetiapine—CYP2D6—Parkinson's disease	4.1e-05	0.00439	CrCbGaD
Acetophenazine—DRD2—Signaling Pathways—GFAP—Parkinson's disease	4.05e-05	0.000613	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—GRM5—Parkinson's disease	4e-05	0.000606	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—FGB—Parkinson's disease	3.93e-05	0.000595	CbGpPWpGaD
Acetophenazine—DRD1—Signaling by GPCR—HTR2A—Parkinson's disease	3.92e-05	0.000594	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—HTR1A—Parkinson's disease	3.91e-05	0.000592	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—TAC1—Parkinson's disease	3.85e-05	0.000583	CbGpPWpGaD
Acetophenazine—Fluphenazine—ABCB1—Parkinson's disease	3.78e-05	0.00404	CrCbGaD
Acetophenazine—DRD2—Circadian rythm related genes—IL6—Parkinson's disease	3.75e-05	0.000568	CbGpPWpGaD
Acetophenazine—DRD2—GPCR downstream signaling—EDN1—Parkinson's disease	3.73e-05	0.000565	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—DRD3—Parkinson's disease	3.66e-05	0.000554	CbGpPWpGaD
Acetophenazine—Chlorpromazine—HTR2A—Parkinson's disease	3.63e-05	0.00388	CrCbGaD
Acetophenazine—DRD2—Signaling Pathways—FGF20—Parkinson's disease	3.51e-05	0.000532	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—ADRBK1—Parkinson's disease	3.42e-05	0.000517	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—ADORA2A—Parkinson's disease	3.41e-05	0.000515	CbGpPWpGaD
Acetophenazine—DRD2—Signaling by GPCR—EDN1—Parkinson's disease	3.39e-05	0.000513	CbGpPWpGaD
Acetophenazine—Chlorpromazine—CYP2D6—Parkinson's disease	3.32e-05	0.00355	CrCbGaD
Acetophenazine—DRD1—Signaling Pathways—HTR7—Parkinson's disease	3.31e-05	0.000501	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—DRD2—Parkinson's disease	3.31e-05	0.000501	CbGpPWpGaD
Acetophenazine—DRD2—GPCR downstream signaling—HTR2A—Parkinson's disease	3.26e-05	0.000494	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—INSR—Parkinson's disease	3.14e-05	0.000476	CbGpPWpGaD
Acetophenazine—Trifluoperazine—ABCB1—Parkinson's disease	3.02e-05	0.00323	CrCbGaD
Acetophenazine—DRD2—Signaling Pathways—FGB—Parkinson's disease	2.97e-05	0.00045	CbGpPWpGaD
Acetophenazine—DRD2—Signaling by GPCR—HTR2A—Parkinson's disease	2.96e-05	0.000449	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—HTR1A—Parkinson's disease	2.95e-05	0.000447	CbGpPWpGaD
Acetophenazine—Quetiapine—ABCB1—Parkinson's disease	2.93e-05	0.00314	CrCbGaD
Acetophenazine—DRD2—Signaling Pathways—TAC1—Parkinson's disease	2.91e-05	0.00044	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—DRD1—Parkinson's disease	2.85e-05	0.000432	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—IGF2—Parkinson's disease	2.77e-05	0.00042	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—DRD3—Parkinson's disease	2.76e-05	0.000418	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—IGF1R—Parkinson's disease	2.68e-05	0.000406	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—EDN1—Parkinson's disease	2.65e-05	0.000401	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	2.58e-05	0.000391	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—HTR7—Parkinson's disease	2.5e-05	0.000378	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—NGF—Parkinson's disease	2.44e-05	0.000369	CbGpPWpGaD
Acetophenazine—Chlorpromazine—ABCB1—Parkinson's disease	2.37e-05	0.00254	CrCbGaD
Acetophenazine—DRD1—Signaling Pathways—HTR2A—Parkinson's disease	2.32e-05	0.000351	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—APOE—Parkinson's disease	2.16e-05	0.000326	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—IGF2—Parkinson's disease	2.09e-05	0.000317	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	2.03e-05	0.000307	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—EDN1—Parkinson's disease	2e-05	0.000303	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—INS—Parkinson's disease	1.84e-05	0.000279	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—NGF—Parkinson's disease	1.84e-05	0.000278	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	1.75e-05	0.000265	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—APOE—Parkinson's disease	1.63e-05	0.000246	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—INS—Parkinson's disease	1.39e-05	0.00021	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—CASP3—Parkinson's disease	1.37e-05	0.000208	CbGpPWpGaD
Acetophenazine—DRD1—Signaling by GPCR—IL6—Parkinson's disease	1.36e-05	0.000206	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—MAPK8—Parkinson's disease	1.26e-05	0.000191	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—CASP3—Parkinson's disease	1.04e-05	0.000157	CbGpPWpGaD
Acetophenazine—DRD2—Signaling by GPCR—IL6—Parkinson's disease	1.03e-05	0.000156	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	9.51e-06	0.000144	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—IL6—Parkinson's disease	8.05e-06	0.000122	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—IL6—Parkinson's disease	6.07e-06	9.2e-05	CbGpPWpGaD
